Amid a rebound in SPAC activity, the prolific “crossover” investor is aiming for its third blank-check merger since 2022 ...

Two Texas-based biotechnology companies are joining forces on a mission to reverse extinction. Colossal Biosciences Inc., the Dallas-based genetics company who claimed to have brought back the dire ...

Colossal Biosciences has announced its first acquisition, bringing Viagen Pets and Equine, the world leader in animal cloning, into its growing biotechnology family. Viagen made headlines a few years ...

Halozyme is paying as much as $400 million for a drug delivery specialist that could boost its growth prospects, one analyst ...

The Boulder biotech company, founded in 2000, will remain and become a proteomics center for its new owner.

With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industry Niagen Bioscience, Inc. (NASDAQ: NAGE), ...

Tom Brady recently revealed that he had his beloved pit bull Lua cloned after she passed in 2023. The company behind the science, Viagen -- which is also responsible for other high-profile pet clones ...

Taconic Biosciences, Inc., a global leader in genetically engineered rodent models (GEMs) and humanized immune system (HIS) mouse models, today announced the acquisition of TransCure bioServices SAS, ...

AUSTIN (KXAN) — An Austin-based company was acquired by Colossal Biosciences, a biosciences company that has claimed to “de-extinct” animals, according to a Tuesday announcement. Viagen Pets and ...

Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics.